J.M. Andrieu

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

J.M. Tourani, C. Pfister, J.F. Berdah et al. · Journal of Clinical Oncology · 1998 · 78 citations

Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France

Jacques Young, Jérôme Bertherat, Marie‐Christine Vantyghem et al. · European Journal of Endocrinology · 2018 · 63 citations

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient

Claude Soubrane, J.M. Tourani, J.M. Andrieu et al. · Blood · 1993 · 50 citations

Changes of Soluble CD16 Levels in Serum of HIV-Infected Patients: Correlation with Clinical and Biologic Prognostic Factors

D. Khayat, C. Soubrane, J.M. Andrieu et al. · The Journal of Infectious Diseases · 1990 · 47 citations

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient

C. Soubrane, J.M. Tourani, J.M. Andrieu et al. · Blood · 1993 · 42 citations · Full text